The diagnosis and clinical management of the neuropsychiatric manifestations of lupus
- PMID: 27427403
- DOI: 10.1016/j.jaut.2016.06.013
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus
Abstract
Neuropsychiatric (NP) involvement in Systemic Lupus Erythematosus (SLE), can be a severe and troubling manifestation of the disease that heavily impacts patient's health, quality of life and disease outcome. It is one of the most complex expressions of SLE which can affect central, peripheral and autonomous nervous system. Complex interrelated pathogenetic mechanisms, including genetic factors, vasculopathy, vascular occlusion, neuroendocrine-immune imbalance, tissue and neuronal damage mediated by autoantibodies, inflammatory mediators, blood brain barrier dysfunction and direct neuronal cell death can be all involved. About NPSLE a number of issues are still matter of debate: from classification and burden of NPSLE to attribution and diagnosis. The role of neuroimaging and new methods of investigation still remain pivotal and rapidly evolving as well as is the increasing knowledge in the pathogenesis. Overall, two main pathogenetic pathways have been recognized yielding different clinical phenotypes: a predominant ischemic-vascular one involving large and small blood vessels, mediated by aPL, immune complexes and leuko-agglutination which it is manifested with more frequent focal NP clinical pictures and a predominantly inflammatory-neurotoxic one mediated by complement activation, increased permeability of the BBB, intrathecal migration of autoantibodies, local production of immune complexes and pro-inflammatory cytokines and other inflammatory mediators usually appearing as diffuse NP manifestations. In the attempt to depict a journey throughout NPSLE from diagnosis to a reasoned therapeutic approach, classification, epidemiology, attribution, risk factors, diagnostic challenges, neuroimaging techniques and pathogenesis will be considered in this narrative review based on the most relevant and recent published data.
Keywords: Central and peripheral nervous system; Neuroimaging; Neuropsychiatric lupus; Systemic Lupus Erythematosus.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus.Expert Rev Clin Immunol. 2019 Apr;15(4):407-416. doi: 10.1080/1744666X.2019.1564040. Epub 2019 Jan 14. Expert Rev Clin Immunol. 2019. PMID: 30632405 Review.
-
Central Nervous System Manifestations of Systemic Lupus Erythematosus.Rheum Dis Clin North Am. 2017 Nov;43(4):531-545. doi: 10.1016/j.rdc.2017.06.003. Epub 2017 Aug 23. Rheum Dis Clin North Am. 2017. PMID: 29061240 Review.
-
[Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].Rev Med Interne. 2012 Sep;33(9):491-502. doi: 10.1016/j.revmed.2012.03.356. Epub 2012 May 11. Rev Med Interne. 2012. PMID: 22579860 Review. French.
-
Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).Best Pract Res Clin Rheumatol. 2002 Apr;16(2):229-44. doi: 10.1053/berh.2001.0223. Best Pract Res Clin Rheumatol. 2002. PMID: 12041951 Review.
-
Pathogenesis and treatment of CNS lupus.Curr Opin Rheumatol. 2013 Sep;25(5):577-83. doi: 10.1097/BOR.0b013e328363eaf1. Curr Opin Rheumatol. 2013. PMID: 23836074 Review.
Cited by
-
Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients.Clin Rheumatol. 2022 Feb;41(2):421-428. doi: 10.1007/s10067-021-05915-0. Epub 2021 Sep 19. Clin Rheumatol. 2022. PMID: 34537904
-
Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus.Rheumatol Int. 2017 Dec;37(12):1999-2004. doi: 10.1007/s00296-017-3819-x. Epub 2017 Sep 22. Rheumatol Int. 2017. PMID: 28940018 Review.
-
The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement.Front Immunol. 2019 Mar 19;10:514. doi: 10.3389/fimmu.2019.00514. eCollection 2019. Front Immunol. 2019. PMID: 30941143 Free PMC article.
-
Temporal and spatial changes in cerebral blood flow in neuropsychiatric systemic lupus erythematosus: a subtraction brain spect study.Eur J Hybrid Imaging. 2021 Nov 4;5(1):19. doi: 10.1186/s41824-021-00112-3. Eur J Hybrid Imaging. 2021. PMID: 34734310 Free PMC article.
-
The introspection on the diagnosis and treatment process of a case of Guillain-Barré syndrome (GBS) attributed to systemic lupus erythematosus (SLE): A case report.Medicine (Baltimore). 2017 Dec;96(49):e9037. doi: 10.1097/MD.0000000000009037. Medicine (Baltimore). 2017. PMID: 29245299 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous